The follistatin:myostatin ratio was significantly increased in SMA subjects (10.39; 3.28–75.9) compared to controls (1.55; 0.73–5.15, P < 0.001 corrected for weight or BMI, Fig. 5A). The gene discussed is MSTN; the disease is proximal spinal muscular atrophy.